# Tomas Olsson

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/tomas-olsson/

## Facts

| Field | Value |
| --- | --- |
| Citations | 59,446 |
| Field | Multiple Sclerosis Research Studies |
| h-index | 119 |
| i10-index | 640 |
| Last Known Institution | Karolinska University Hospital |
| OpenAlex ID | https://openalex.org/A5015275115 |
| ORCID iD | https://orcid.org/0000-0002-2938-1877 |
| Works | 1,004 |

## Researcher papers

- [Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology](https://scholariq.org/papers/diagnostic-value-of-cerebrospinal-fluid-neurofilament-light-protein-in-neurology/)
- [ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis](https://scholariq.org/papers/ectrims-ean-guideline-on-the-pharmacological-treatment-of-people-with-multiple/)
- [Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: Recommendations for clinical practice](https://scholariq.org/papers/vitamin-d-and-musculoskeletal-health-cardiovascular-disease-autoimmunity-and/)
- [Variation in interleukin 7 receptor α chain (IL7R) influences risk of multiple sclerosis](https://scholariq.org/papers/variation-in-interleukin-7-receptor-chain-il7r-influences-risk-of-multiple/)
- [Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study](https://scholariq.org/papers/conversion-from-clinically-isolated-syndrome-to-multiple-sclerosis-a-large/)
- [Systemic Inflammation in Progressive Multiple Sclerosis Involves Follicular T-Helper, Th17- and Activated B-Cells and Correlates with Progression](https://scholariq.org/papers/systemic-inflammation-in-progressive-multiple-sclerosis-involves-follicular-t/)
- [Locus for severity implicates CNS resilience in progression of multiple sclerosis](https://scholariq.org/papers/locus-for-severity-implicates-cns-resilience-in-progression-of-multiple/)
- [Increased cerebrospinal fluid concentrations of the chemokine CXCL13 in active MS](https://scholariq.org/papers/increased-cerebrospinal-fluid-concentrations-of-the-chemokine-cxcl13-in-active/)
- [DNA methylation as a mediator of HLA-DRB1*15:01 and a protective variant in multiple sclerosis](https://scholariq.org/papers/dna-methylation-as-a-mediator-of-hla-drb1-15-01-and-a-protective-variant-in/)
- [Network-Based Multiple Sclerosis Pathway Analysis with GWAS Data from 15,000 Cases and 30,000 Controls](https://scholariq.org/papers/network-based-multiple-sclerosis-pathway-analysis-with-gwas-data-from-15-000/)
- [FLT3 stop mutation increases FLT3 ligand level and risk of autoimmune thyroid disease](https://scholariq.org/papers/flt3-stop-mutation-increases-flt3-ligand-level-and-risk-of-autoimmune-thyroid/)

## Researcher topics

- [Multiple Sclerosis Research Studies](https://scholariq.org/topics/multiple-sclerosis-research-studies/)
- [T-cell and B-cell Immunology](https://scholariq.org/topics/t-cell-and-b-cell-immunology/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)
- [Peripheral Neuropathies and Disorders](https://scholariq.org/topics/peripheral-neuropathies-and-disorders/)
- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)

## Researcher university

- [Karolinska University Hospital](https://scholariq.org/institutions/karolinska-university-hospital/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.